Cassava Sciences, Inc. (SAVA)
3.08
-0.07
(-2.22%)
USD |
NASDAQ |
Dec 12, 10:45
Cassava Sciences Research and Development Expense (TTM): 43.27M for Sept. 30, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Biogen, Inc. | 1.524B |
| Geron Corp. | 81.32M |
| Ovid Therapeutics, Inc. | 24.66M |
| NovaBay Pharmaceuticals, Inc. | -- |
| Palatin Technologies, Inc. | 11.68M |